In this webinar, dated 20 June 2023, you can learn from Prof. Lieven Annemans, faculty member of CELforPharma's courses on Health Economics for Non-Health-Economists and Health Technology Assessment, and well known for his broad HECON/HTA expertise and excellent presentation skills, about:
The state of the art for measuring QALYs
The value of a QALY
Measuring health gains: beyond the QALY
🎓 If you want to learn about:
- The logic and mathematics behind QALYs, ICERs, decision trees and Markov models.
- How external stakeholders use and challenge health economic evidence.
- How to distinguish good from bad health economic evaluation studies (of your brand or its competitors).
- Key principles of cost-effectiveness analysis and Budget Impact Analysis.
- The role of health economic evaluations in clinical research, pricing & reimbursement decisions, and post-launch.
👉 Attend Prof. Dr Lieven Annemans’ highly praised 2-day course:
Health Economics for Non-Health-Economists
With Prof. Dr Lieven Annemans
🎓 If you want to learn about:
- The different types of HTAs in Europe.
- How to address the broad and evolving range of assessment criteria in Europe.
- How to optimise clinical evidence generation for HTA bodies.
- How to use Real-World Data for HTA purposes.
- How to prepare for the Joint Clinical Assessment (JCA) in the EU.
👉 Attend Prof. Dr Lieven Annemans' highly praised 1-day course:
Critical New HTA Developments in Europe: Challenges & Solutions
With Prof. Dr Lieven Annemans